Qiao, X., Zhou, Z., Niu, R., Su, Y., Sun, Y., Liu, H., . . . Cheng, X. (2019). Hydroxychloroquine Improves Obesity-Associated Insulin Resistance and Hepatic Steatosis by Regulating Lipid Metabolism. Front Pharmacol.
Chicago-tyylinen lähdeviittausQiao, Xin, et al. "Hydroxychloroquine Improves Obesity-Associated Insulin Resistance and Hepatic Steatosis By Regulating Lipid Metabolism." Front Pharmacol 2019.
MLA-viiteQiao, Xin, et al. "Hydroxychloroquine Improves Obesity-Associated Insulin Resistance and Hepatic Steatosis By Regulating Lipid Metabolism." Front Pharmacol 2019.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.